Monitor upcoming CE mark approval timeline (late Q4 2026 / early Q1 2027) and next quarterly filing for revenue and margin data to validate commercial traction.
Price Chart
Executive Summary
Microbot Medical issued a press release summarizing its commercial and growth strategy, highlighting expansion to 12 U.S. sales territories by year-end, its first California customer, and a user survey showing high satisfaction with the LIBERTY System. The filing is a routine business update with no financial data, guidance, or material events.
Key Facts
- Company on track to have 12 U.S. sales territories by end of 2026.
- Secured first customer in California and expanding in North Carolina.
- Hired three additional Area Sales Managers and one Regional Sales Director.
- Engaged with Value Analysis Committees (VAC) at multiple health systems.
- Expects positive gross margins in 2027 from adding a second manufacturing line.
- CE mark approval expected in late Q4 2026 or early Q1 2027.
- Potential international expansions in Asia and Middle East in advanced stages.
Financial Impact
No financial figures reported; qualitative operational update only.
Risk Factors
- No revenue or financial data provided to substantiate commercial progress.
- CE mark approval timeline may slip beyond guided window.
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-044429 |
| Exhibit: ex10-1.htm | 0001493152-26-044429 |
| Document: 0001493152-26-044429-index-headers.html | 0001493152-26-044429 |
| Document: 0001493152-26-044429-index.html | 0001493152-26-044429 |
| Document: 0001493152-26-044429.txt | 0001493152-26-044429 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | 8-K | $0.9570 | awaiting T+1 | — | $1.03 (+7.63%) |
Oct 23, 2026 4d ago | 8-K | $0.9739 $0.9417 | ▼ −3.31% | ▼ −4.02% | $1.03 (+5.76%) |
Oct 20, 2026 7d ago | 8-K | $0.9475 $0.9401 | ▼ −0.78% | ▼ −1.31% | $1.03 (+8.71%) |
Oct 6, 2026 21d ago | 8-K | $1.07 $1.12 | ▲ +4.67% | ▲ +4.91% | $1.03 (−3.74%) |
Oct 6, 2026 21d ago | Press Release | $1.07 $1.12 | ▲ +4.67% | ▲ +4.91% | $1.03 (−3.74%) |
Sep 28, 2026 29d ago | 8-K | $1.25 $1.25 | ▼ −0.40% | ▼ −0.22% | $1.03 (−17.60%) |
Aug 11, 2026 11w ago | 8-K | $1.68 $1.74 | ▲ +3.27% | ▲ +3.02% | $1.03 (−38.69%) |
Jul 21, 2026 14w ago | 8-K | $1.80 $1.77 | ▼ −1.67% | ▼ −1.55% | $1.03 (−42.78%) |
Jul 7, 2026 16w ago | 8-K | $1.90 $1.87 | ▼ −1.58% | ▼ −1.27% | $1.03 (−45.79%) |
Jun 30, 2026 17w ago | 8-K | $1.95 $1.91 | ▼ −2.05% | ▼ −1.92% | $1.03 (−47.18%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers